Results for tag: "Generalized Anxiety Disorder Drug"

The Generalized Anxiety Disorder Drug market is a subset of the larger Anxiety Drugs market. It consists of medications used to treat Generalized Anxiety Disorder (GAD), a mental health disorder characterized by excessive and persistent worry and fear. These drugs are typically prescribed by psychiatrists and other mental health professionals. Commonly prescribed drugs include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and benzodiazepines. The Generalized Anxiety Disorder Drug market is highly competitive, with many pharmaceutical companies offering a variety of medications. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca, and Novartis. Other companies, such as Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals, also offer medications for GAD. Show Less Read more